Small bowel atresia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
May 2022

TPOXX: FDA approved

Treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 3 kg

FDAcompleted
Jun 2021

Tembexa: FDA approved

Treatment of human smallpox disease caused by variola virus in adult and pediatric patients, including neonates

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

TPOXX

SIGA Technologies, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Tembexa

(brincidofovir)Orphan drug

Emergent BioDefense Operations Lansing LLC

12.1 Mechanism of Action Brincidofovir is an antiviral drug against variola (smallpox) virus [see Microbiology ( 12.4 )] .

Approved Jun 2021FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Small bowel atresia.
Search all trials →
Search clinical trials for Small bowel atresia

Recent News & Research

No recent news articles indexed yet for Small bowel atresia.
Search PubMed for Small bowel atresia

Browse all Small bowel atresia news →

Specialist Network

No specialists currently listed for Small bowel atresia.

View all Small bowel atresia specialists →

Quick Actions